Concerns over unregulated peptide availability involving the Therapeutic Goods Administration and Dan Repacholi.
3 reports, 3 independent
Updated Aug 12
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Concerns over unregulated peptide availability involving the Therapeutic Goods Administration and Dan Repacholi.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.The unregulated gray market for peptides is expanding.1 source
Concerns over unregulated peptide availability.1 source
Keep exploring
The entities involved
-
Therapeutic Goods Administration
regulatory body for therapeutic goods (including medicines, medical devices, gene technology, and blood products) in Australia
-
Dan Repacholi
Australian sport shooter and politician
Nothing else this week.